上海之江生物科技股份有限公司关于2025年第三次以集中竞价交易方式回购股份方案的公告

Core Viewpoint - Shanghai Zhijiang Biological Technology Co., Ltd. plans to repurchase its shares through centralized bidding, with a total amount between RMB 60 million and RMB 120 million, aimed at employee stock ownership plans or equity incentives [2][3][31] Summary by Sections Repurchase Plan Details - The repurchase amount will not be less than RMB 60 million and not exceed RMB 120 million [2][17] - The funding sources for the repurchase will be the company's own funds and special loan funds for stock repurchase, with a loan commitment letter obtained from Beijing Bank [2][19] - The repurchase price will not exceed RMB 37.99 per share, which is 150% of the average trading price over the last 30 trading days prior to the board's decision [3][18] - The repurchase will be conducted through centralized bidding [4][11] - The repurchase period is set for 12 months from the board's approval date [5][12] Purpose and Use of Repurchased Shares - The repurchased shares are intended for employee stock ownership plans or equity incentives, promoting a long-term incentive mechanism [9][31] - If the shares are not transferred within three years after the repurchase, the company will reduce its registered capital accordingly [23][31] Board Meeting and Approval - The board meeting to approve the repurchase plan was held on October 15, 2025, with unanimous approval from all attending directors [7][29] - The repurchase plan does not require shareholder meeting approval as per relevant regulations [8][31] Financial Impact and Structure - As of June 30, 2025, the company's total assets were approximately RMB 3.78 billion, and the net assets attributable to shareholders were about RMB 3.45 billion [20][21] - The repurchase funds will account for approximately 3.18% of total assets and 3.48% of net assets, indicating a manageable impact on the company's financials [20][21] Shareholder and Management Plans - Major shareholders and management have no plans to reduce their holdings in the next three to six months [5][22][31] - The company will comply with legal obligations for information disclosure if any changes occur in shareholding plans [22][31]